Pyrazolopyrimidines as Potent Stimulators for Transient Receptor Potential Canonical 3/6/7 Channels.

about

Pyrazolopyrimidines as Potent Stimulators for Transient Receptor Potential Canonical 3/6/7 Channels.

Item

http://www.wikidata.org/entity/Q40250028

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pyrazolopyrimidines as Potent ...... tial Canonical 3/6/7 Channels.

@en

type

Item

label

Pyrazolopyrimidines as Potent ...... tial Canonical 3/6/7 Channels.

@en

prefLabel

Pyrazolopyrimidines as Potent ...... tial Canonical 3/6/7 Channels.

@en

P1476

Pyrazolopyrimidines as Potent ...... tial Canonical 3/6/7 Channels.

@en

P2093

Aga Er-Bu

http://www.w3.org/2001/XMLSchema#string

Bing Shen

http://www.w3.org/2001/XMLSchema#string

Chunrong Qu

http://www.w3.org/2001/XMLSchema#string

Hongbo Wang

http://www.w3.org/2001/XMLSchema#string

Huai-Rong Luo

http://www.w3.org/2001/XMLSchema#string

Jian Xu

http://www.w3.org/2001/XMLSchema#string

Jilin Wu

http://www.w3.org/2001/XMLSchema#string

Jinbin Tian

http://www.w3.org/2001/XMLSchema#string

Jinmei Zhu

http://www.w3.org/2001/XMLSchema#string

Juan Du

http://www.w3.org/2001/XMLSchema#string

P2860

Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol

Molecular and functional characterization of a novel mouse transient receptor potential protein homologue TRP7. Ca(2+)-permeable cation channel that is constitutively activated and enhanced by stimulation of G protein-coupled receptor

2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3

TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function

TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.

Activation of TRPA1 channels by fenamate nonsteroidal anti-inflammatory drugs

Physiological Function and Characterization of TRPCs in Neurons

Identification of ML204, a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels

Novel pharmacological TRPC inhibitors block hypoxia-induced vasoconstriction.

A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis.

P304

4680-4692

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.JMEDCHEM.7B00304

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xuechuan Hong

P577

2017-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28395140

http://www.w3.org/2001/XMLSchema#string

P932

5720685

http://www.w3.org/2001/XMLSchema#string